Replies to post #249650 on Biotech Values

[DewDiligence]

BHC acquires DRRX for $1.75/sh +CVR—a 217% premium to yesterday’s closing price (excluding the CVR):

https://finance.yahoo.com/news/bausch-health-acquire-durect-corporation-110000355.html

The nominal deal value (excluding the CVR) is $63M.